Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats

Neurogastroenterology and Motility

Volumn 26, Issue 12, 2014, Pages 1694-1704

  Kannampalli, P ^a   Pochiraju, S ^a   Chichlowski, M ^b   Berg, B M ^b   Rudolph, C ^b   Bruckert, M ^a   Miranda, A ^a   Sengupta, J N ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Mead Johnson Nutritionals   (United States)

Author keywords

LGG; Neurotransmitter; Probiotic; Visceral hyperalgesia

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; PREBIOTIC AGENT; PROBIOTIC AGENT; ZYMOSAN;

ANIMAL; BIOSYNTHESIS; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; HYPERALGESIA; INFLAMMATION; INTESTINE; LACTOBACILLUS RHAMNOSUS; MANOMETRY; METABOLISM; NEWBORN; RAT; SPRAGUE DAWLEY RAT; VISCERAL PAIN;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DISEASE MODELS, ANIMAL; HYPERALGESIA; INFLAMMATION; INTESTINES; LACTOBACILLUS RHAMNOSUS; MANOMETRY; NEUROTRANSMITTER AGENTS; PREBIOTICS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; VISCERAL PAIN; ZYMOSAN;

EID: 84911483659     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12450     Document Type: Article

References (55)

1. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-93.
2. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 31-9.
3. Walker-Smith J. Cow's milk allergy: a new understanding from immunology. Ann Allergy Asthma Immunol 2003; 90: 81-3.
4. Magazzù G, Scoglio R. Gastrointestinal manifestations of cow's milk allergy. Ann Allergy Asthma Immunol 2002; 89: 65-8.
5. Lake AM, Whitington PF, Hamilton SR. Dietary protein- induced colitis in breast-fed infants. J Pediatr 1982; 101: 906-10.
6. Saps M, Lu P, Bonilla S. Cow's-milk allergy is a risk factor for the development of FGIDs in children. J Pediatr Gastroenterol Nutr 2011; 52: 166-9.
7. Lidow MS. Long-term effects of neonatal pain on nociceptive systems. Pain 2002; 99: 377-83.
8. Melzack R, Scott TH. The effects of early experience on the response to pain. J Comp Physiol Psychol 1957; 50: 155-61.
9. Ren K, Anseloni V, Zou SP, Wade EB, Novikova SI, Ennis M, Traub RJ, Gold MS et al. Characterization of basal and re-inflammation associated long term alteration in pain responsivity following short lasting neonatal inflammatory insult. Pain 2004; 110: 588-96.
10. Sikander S, Dickenson AH. Visceral painL ins and outs, the ups and downs. Curr Opin Support Palliate Care 2012; 6: 17-26.
11. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25: 386-94.
12. Farmer AD, Aziz Q. Visceral pain hypersensitivity in functional gastrointestinal disorders. Br Med Bull 2009; 91: 123-36.
13. Konturek SJ, Pawlik WW, Dajani EZ. Brain-gut axis in gastrointestinal system: introductory remarks. J Physiol Pharmacol 2003; 54: 3-7.
14. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011; 6: 209-40.
15. Ohman L, Simrén M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013; 15: 323.
16. de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 2013; 131: e550-8.
17. Collins SM, Chang C, Mearin F. Postinfectious chronic gut dysfunction: from bench to bedside. Am J Gastroenterol Suppl 2012; 1: 2-8.
18. Cash BD. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome. Curr Med Res Opin 2014; 30: 1405-1415. [Epub ahead of print].
19. Aragon G, Graham DB, Borum M, Doman DB. Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (N Y) 2010; 6: 39-44.
20. Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 2013; 162: 257-62.
21. Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 2014; 348: g2107.
22. Pärtty A, Luoto R, Kalliomäki M, Salminen S, Isolauri E. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 2013; 163: 1272-7.
23. Boehm G, Jelinek J, Stahl B, van Laere K, Knol J, Fanaro S, Moro G, Vigi V. Prebiotics in infant formulas. J Clin Gastroenterol 2004; 38: S76-9.
24. Scalabrin DM, Mitmesser SH, Welling GW, Harris CL, Marunycz JD, Walker DC, Bos NA, Tölkkö S et al. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. J Pediatr Gastroenterol Nutr 2012; 54: 343-52.
25. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55: 182-90.
26. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in rats. Neurogastroenterol Motil 2010; 22: 1026-e268.
27. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170: 1178-89.
28. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 2009; 296: G868-75.
29. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 35-7.
30. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010; 7: 503-14.
31. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA 2010; 107: 454-9.
32. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-12.
33. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011; 23: 187-92.
34. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010; 24: 9-16.
35. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-14.
36. Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis G, Burnet PW. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 2013; 63: 756-64.
37. Kannampalli P, Pochiraju S, Bruckert M, Shaker R, Banerjee B, Sengupta JN. Analgesic effect of minocycline in rat model of inflammation-induced visceral pain. Eur J Pharmacol 2014; 727: 87-98.
38. Cohen SA, Michaud DP. Synthesis of a fluorescent derivatizing reagent 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acid via high performance liquid chromatography. Anal Biochem 1993; 211: 279-87.
39. Lindley JW, Jung AE, Narayanan TK, Ritchie GD. Acute effects of a bicyclophosphate neuroconvulsant on monoamine neurotransmitter and metabolite levels in the rat brain. J Toxicol Envir Health 1998; 54: 421-9.
40. Walter J. Ecological role of Lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 2008; 74: 4985-96.
41. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmühl Y, Fischer D, Holsboer F, Wotjak CT et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009; 12: 1559-66.
42. Gareau MG, Silva MA, Perdue MH. Pathophysiological mechanisms of stress-induced intestinal damage. Curr Mol Med 2008; 8: 274-81.
43. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-51.
44. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Versalovic J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS ONE 2002; 7: e31951.
45. Hemarajata P, Gao C, Pflughoeft KJ, Thomas CM, Saulnier DM, Spinler JK, Versalovic J. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri. J Bacteriol 2013; 195: 5567-76.
46. Frederick AL, Stanwood GD. Drugs, biogenic amine targets and the developing brain. Dev Neurosci 2009; 31: 7-22.
47. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011; 108: 16050-5.
48. Bardin L. The complex role of serotonin and 5-HT receptors in chronic pain. Behav Pharmacol 2011; 22: 390-404.
49. Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 2004; 30: 117-25.
50. Pertovaara A, Kauppila T, Jyvasjarvi E, Kalso E. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced anti-nociception. Neuroscience 1991; 44: 705-14.
51. Thor KB, Kirby M, Viktrup L. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int J Clin Pract 2007; 61: 1349-55.
52. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8: 781-97.
53. van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L, Bienenstock J. Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1131-7.
54. Wijayatunge R, Chen LF, Cha YM, Zannas AS, Frank CL, West AE. The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival. Mol Cell Neurosci 2014; 61: 187-200.
55. Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 2014; 4: 28.